Eli Lilly flies the pharma flag in tech-heavy $1tn market cap club
Fuelled by weight loss drug sales, Eli Lilly achieves a feat no healthcare company has before.
Therapy Area
“Reckless and harmful”: experts weigh in on CDC’s autism-vaccine link stance
Aspen closes $115m in Series C to advance Parkinson’s cell therapy
Regeneron’s Eylea franchise boosted by pair of FDA approvals
Pfizer and Tris reach settlement with Texas over ADHD drug allegations
Arrowhead nets first commercial win as siRNA drug garners FDA approval
CSL to pump $1.5bn into US plasma supply chain
USPTO grants patent to Genprex’s Reqorsa gene therapy
